why choose us

First received: December 14, 2022

Clinical Trial: Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Leukemia
Myeloid
Acute
Newly Diagnosed

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2a, First-in-human, Open-label, Multicenter, Dose Escalation Study of MP0533 in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and preliminary activity of MP0533 in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)

Read more